Entering text into the input field will update the search result below

CNS Pharmaceuticals reports FY results

Mar. 03, 2022 8:50 AM ETCNS Pharmaceuticals, Inc. (CNSP)By: Deepa Sarvaiya, SA News Editor
  • CNS Pharmaceuticals press release (NASDAQ:CNSP): FY Net Loss of $14M
  • As of December 31, 2021, the Company had cash of approximately $5M and working capital of approximately $5.3M.
  • Shares -1.24% PM.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.